Business Class
Applying production-line philosophy to pharmacy?
How assembly line theory can help maximise efficiency and effectiveness in community pharmacy, by Glenn Guilfoyle Readers of the trade press over recent months will have had opportunity to digest the …
The right value?
What are the lessons from the recent pharmacy valuation season? John Thornett explains Since 30 June 2018 valuation activity has certainly been very high. We have seen activity pick up …
Capital gains
What determines a pharmacy’s capitalisation rate? Natalie Sirianni explains Pharmacy businesses are valued using the Capitalisation of Future Maintainable Earnings methodology. This means that mathematically there are two factors in …
5 hidden pitfalls in ‘standard’ franchise agreements
You may be aware of the benefits of entering into franchise agreements for the purpose of trading under a brand name. But are you also aware of the pitfalls? By …
Pharmacy market update
We’re now in the final quarter of the 2018 calendar year, and Natalie Sirianni reviews and assesses the year to date in terms of pharmacy business sales It has been …
Accelerating your services
Sorting out your pharmacy’s workflow is crucial to transforming its health services and value to patients say Glenn Guilfoyle and Paul Jaffar There is much ado about the advent of …
Be prepared against data breaches
Here’s what you need to know about the new laws that require notification regarding patient data breaches, by Stephanie McGrath Earlier this year, Australia enacted laws requiring businesses to notify patients, …
Having too much of a good thing
Bruce Annabel and Mal Scrymgeour explore whether pharmacy is trying to have its cake (or calamari) and eat it as well We both like hot and spicy Calamari. On those …
Diagnosing pharmacy’s terminology issues
Does pharmacy have a problem with the way it thinks about, and refers to, patient diagnosis? Glenn Guilfoyle and Jenny Blair thinks it does, and that it may have unintended …
How to fix your cash flow
Cash flow is tightening in most pharmacies, but what can you do about it? John Thornett looks at the options We have the advantage of seeing the financial data of …
